Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 41% ± 15% | |
peripheral blood | 18 studies | 31% ± 12% | |
intestine | 11 studies | 31% ± 15% | |
kidney | 9 studies | 45% ± 14% | |
eye | 8 studies | 41% ± 16% | |
brain | 8 studies | 27% ± 8% | |
liver | 6 studies | 35% ± 20% | |
bone marrow | 5 studies | 26% ± 7% | |
uterus | 5 studies | 40% ± 20% | |
lymph node | 5 studies | 39% ± 11% | |
pancreas | 4 studies | 47% ± 25% | |
placenta | 4 studies | 48% ± 25% | |
prostate | 4 studies | 37% ± 11% | |
breast | 4 studies | 36% ± 7% | |
adrenal gland | 3 studies | 31% ± 5% | |
esophagus | 3 studies | 45% ± 24% | |
skin | 3 studies | 28% ± 7% | |
thymus | 3 studies | 53% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 2188.76 | 21 / 21 | 100% | 69.80 | 504 / 504 |
esophagus | 100% | 1967.02 | 1445 / 1445 | 100% | 53.95 | 183 / 183 |
liver | 100% | 1607.79 | 226 / 226 | 100% | 45.76 | 406 / 406 |
lung | 100% | 2430.20 | 578 / 578 | 100% | 58.44 | 1155 / 1155 |
ovary | 100% | 2359.44 | 180 / 180 | 100% | 84.93 | 430 / 430 |
skin | 100% | 2159.31 | 1809 / 1809 | 100% | 72.93 | 472 / 472 |
stomach | 100% | 1921.54 | 359 / 359 | 100% | 61.79 | 286 / 286 |
thymus | 100% | 2225.98 | 653 / 653 | 100% | 61.90 | 605 / 605 |
uterus | 100% | 1850.78 | 170 / 170 | 100% | 64.29 | 459 / 459 |
brain | 100% | 2150.75 | 2641 / 2642 | 100% | 63.67 | 705 / 705 |
kidney | 100% | 6344.04 | 89 / 89 | 100% | 83.97 | 900 / 901 |
intestine | 100% | 2036.33 | 966 / 966 | 100% | 65.95 | 526 / 527 |
prostate | 100% | 2245.23 | 245 / 245 | 100% | 65.13 | 501 / 502 |
adrenal gland | 100% | 2474.55 | 258 / 258 | 100% | 47.77 | 229 / 230 |
breast | 100% | 2565.83 | 459 / 459 | 99% | 60.91 | 1111 / 1118 |
pancreas | 99% | 1037.19 | 326 / 328 | 99% | 57.13 | 177 / 178 |
adipose | 100% | 2562.04 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 82.14 | 29 / 29 |
muscle | 100% | 2727.47 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2566.86 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 44.74 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 47.95 | 1 / 1 |
blood vessel | 100% | 2163.94 | 1332 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 3006.09 | 926 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 2984.72 | 855 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 49.67 | 78 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043154 | Biological process | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0009615 | Biological process | response to virus |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0061462 | Biological process | protein localization to lysosome |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0071230 | Biological process | cellular response to amino acid stimulus |
GO_1905636 | Biological process | positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding |
GO_0008361 | Biological process | regulation of cell size |
GO_1904263 | Biological process | positive regulation of TORC1 signaling |
GO_0019079 | Biological process | viral genome replication |
GO_0032008 | Biological process | positive regulation of TOR signaling |
GO_0038202 | Biological process | TORC1 signaling |
GO_1900182 | Biological process | positive regulation of protein localization to nucleus |
GO_0031902 | Cellular component | late endosome membrane |
GO_0005764 | Cellular component | lysosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005829 | Cellular component | cytosol |
GO_0071986 | Cellular component | Ragulator complex |
GO_1990877 | Cellular component | FNIP-folliculin RagC/D GAP |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | LAMTOR5 |
Protein name | Ragulator complex protein LAMTOR5 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 5) Ragulator complex protein LAMTOR5 (Hepatitis B virus X-interacting protein) (HBV X-interacting protein) (HBX-interacting protein) (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 5) |
Synonyms | HBXIP XIP |
Description | FUNCTION: As part of the Ragulator complex it is involved in amino acid sensing and activation of mTORC1, a signaling complex promoting cell growth in response to growth factors, energy levels, and amino acids . Activated by amino acids through a mechanism involving the lysosomal V-ATPase, the Ragulator plays a dual role for the small GTPases Rag (RagA/RRAGA, RagB/RRAGB, RagC/RRAGC and/or RagD/RRAGD): it (1) acts as a guanine nucleotide exchange factor (GEF), activating the small GTPases Rag and (2) mediates recruitment of Rag GTPases to the lysosome membrane . Activated Ragulator and Rag GTPases function as a scaffold recruiting mTORC1 to lysosomes where it is in turn activated . When complexed to BIRC5, interferes with apoptosome assembly, preventing recruitment of pro-caspase-9 to oligomerized APAF1, thereby selectively suppressing apoptosis initiated via the mitochondrial/cytochrome c pathway . . |
Accessions | ENST00000602858.5 E9PLX3 O43504 A0A8Z5A536 ENST00000474861.6 ENST00000602318.6 ENST00000256644.8 R4GMU8 ENST00000483260.5 |